PROGRAM
PDF files
(Day1) Nov 27, 2025
| Symposium | Title | Name | Chairman | |
|---|---|---|---|---|
| 12:00-13:00 | Registration | |||
| 13:00-13:10 | Opening Remarks | Katsuya Satoh | ||
| Motomasa Tanaka | ||||
| 13:10-14:50 | Diagnosis for Human prion disease | Recent advances in MRI-based approaches for the diagnosis of human prion diseases | Koji Fujita | Yasushi Iwasaki Masaki Takao |
| Boosting Skin/CSF RT-QuIC Assay Sensitivity for Prion Disease with CSF Surrogates 14-3-3 and Total Tau | Wen-Quan Zou | |||
| Specific early electroencephalogram analysis for the early diagnosis of sporadic Creutzfeldt-Jakob disease | Nobuo Sanjo | |||
| CSF biomarkers improve the accuracy of early diagnosis for human prion diseases: A 10-year prospective study (2011–2020) | Katsuya Satoh | |||
| 14:50-15:10 | Poster Viewing | |||
| 15:10-15:45 | Educational lecture | Development of Brain-Targeted Drug Delivery Systems for Nucleic Acid Drugs | Shigeru Kawakami | Katsuya Satoh |
| 15:45-16:30 | Development of Treatment for Human prion disease | Therapeutic Potential of FK506 in Prion Diseases | Takehiro Nakagaki | Kenta Teruya |
| Therapeutic Development for Human Prion Diseases: Current Progress and Challenges | Eun-Kyoung Choi | |||
| 16:30-16:50 | Poster Viewing | |||
| 16:50-17:50 | Oral Presentation of Selected Posters | Monitoring Prion-like Tau Seeding Activity in an Alzheimer's Disease Mouse Model | Yuhe Wu | Motomasa Tanaka |
| PrPC exacerbates demyelination via TREM2-TYROBP | Qing Li | |||
| Therapeutic agents for prion diseases via PrPSc structure | Kazuki Kanemaru | |||
| Oas1a as IFN-stimulated gene limiting prion propagation | Takujiro Homma | |||
| 17:50- | Poster Viewing | |||
| 18:30- | Mixer | |||
(Day2) Nov 28, 2025
| Symposium | Title | Name | Chairman | |
|---|---|---|---|---|
| 9:00-9:30 | Keynote lecture | Food Safety Framework in Japan -Role and Future Challenges of Food Safety Commission of Japan | Shigeki Yamamoto | Yoshifumi IWAMARU |
| 9:30-10:00 | Poster Viewing & Voting | |||
| 10:00-11:30 | Cellular and Molecular Biology, Biophysics for neurodegeneration disease including prion disease | How prion protein monomer conformation and amyloid fibril polymorphism determine yeast strain phenotypes | Takashi Nomura | Atsushi KOBAYASHI Jiyan Ma |
| Activation of Aggrephagy as a Novel Therapeutic Approach to Degrade Protein Aggregates | Gen Matsumoto | |||
| Elucidation of the pathogenesis of human prion diseases using mouse models | Atsushi Kobayashi | |||
| 11:30- | Awarding & Closing Ceremony | |||
